Literature DB >> 21640051

Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship?

C S Derdemezis1, P V Voulgari, A A Drosos, D N Kiortsis.   

Abstract

In the last two decades we have witnessed a boost in scientific interest and knowledge of adipose tissue biology to such an extent that it was promoted to an active endocrine organ. Adipose tissue is not just related to body weight and appetite regulation. It is also implicated in obesity, a low-grade inflammatory state, as well as inflammatory conditions including rheumatoid arthritis (RA), an autoimmune disease where anti- and pro-inflammatory cytokine balance is critical. All major adipose derived products, simply termed adipokines, like leptin, adiponectin, visfatin and resistin, reportedly participate in inflammation and immunity. In this review we explore in depth the relationship between adipose tissue and RA, with focus on possible mechanisms, beyond observations about circulating or synovial levels, and special reference to future perspectives and clinical implications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640051

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  18 in total

1.  Circulating levels of IL-1B+IL-6 cause ER stress and dysfunction in islets from prediabetic male mice.

Authors:  Christina M O'Neill; Christine Lu; Kathryn L Corbin; Poonam R Sharma; Stacey B Dula; Jeffrey D Carter; James W Ramadan; Wenjun Xin; Jae K Lee; Craig S Nunemaker
Journal:  Endocrinology       Date:  2013-07-08       Impact factor: 4.736

2.  Contribution of obesity to the rise in incidence of rheumatoid arthritis.

Authors:  Cynthia S Crowson; Eric L Matteson; John M Davis; Sherine E Gabriel
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

3.  Adiponectin and Its Effects on Acute Leukemia Cells: An Experimental and Bioinformatics Approach.

Authors:  Athanasios N Tsartsalis; Anna Tagka; Athanasios Kotoulas; Daphne Mirkopoulou; Styliani A Geronikolou; Lambrou G
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity.

Authors:  Tamer A Gheita; Iman I El-Gazzar; Reem I El Shazly; Abeer M Nour El-Din; Enas Abdel-Rasheed; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-08-11       Impact factor: 8.317

Review 5.  Improvement in insulin resistance after short-term treatment with abatacept: case report and short review.

Authors:  Francesco Ursini; Daniele Mauro; Saverio Naty; Denis Gagliardi; Rosa Daniela Grembiale
Journal:  Clin Rheumatol       Date:  2012-07-27       Impact factor: 2.980

6.  Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Sang-Cheol Bae; Young Ho Lee
Journal:  Clin Rheumatol       Date:  2012-09-02       Impact factor: 2.980

Review 7.  Metabolic syndrome in rheumatoid arthritis.

Authors:  Iván Ferraz-Amaro; Carlos González-Juanatey; Raquel López-Mejias; Leyre Riancho-Zarrabeitia; Miguel A González-Gay
Journal:  Mediators Inflamm       Date:  2013-01-30       Impact factor: 4.711

8.  Obesity and disease activity in juvenile idiopathic arthritis.

Authors:  Christina F Pelajo; Jorge M Lopez-Benitez; Laurie C Miller
Journal:  Pediatr Rheumatol Online J       Date:  2012-01-12       Impact factor: 3.054

9.  Inhibition of Lipid Accumulation and Cyclooxygenase-2 Expression in Differentiating 3T3-L1 Preadipocytes by Pazopanib, a Multikinase Inhibitor.

Authors:  Anil Kumar Yadav; Byeong-Churl Jang
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting.

Authors:  Estíbaliz Castillero; Ana Isabel Martín; Maria Paz Nieto-Bona; Carmen Fernández-Galaz; María López-Menduiña; María Ángeles Villanúa; Asunción López-Calderón
Journal:  Endocr Connect       Date:  2012-06-08       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.